John D. Sallis

935 total citations
35 papers, 728 citations indexed

About

John D. Sallis is a scholar working on Molecular Biology, Oncology and Nephrology. According to data from OpenAlex, John D. Sallis has authored 35 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Nephrology. Recurrent topics in John D. Sallis's work include Bone health and treatments (10 papers), Parathyroid Disorders and Treatments (9 papers) and Alkaline Phosphatase Research Studies (6 papers). John D. Sallis is often cited by papers focused on Bone health and treatments (10 papers), Parathyroid Disorders and Treatments (9 papers) and Alkaline Phosphatase Research Studies (6 papers). John D. Sallis collaborates with scholars based in Australia, United States and Greece. John D. Sallis's co-authors include Herman S. Cheung, Hector F. DeLuca, Gethin Williams, Howard Rasmussen, Konstantinos D. Demadis, Ravi Misra, Deepu Nair, Maria P. Morgan, Géraldine McCarthy and Anthony S. Wierzbicki and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biomaterials.

In The Last Decade

John D. Sallis

34 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Sallis Australia 16 268 183 181 169 100 35 728
M Richard France 15 229 0.9× 138 0.8× 69 0.4× 50 0.3× 20 0.2× 43 518
Kaiyu Yuan United States 14 523 2.0× 80 0.4× 192 1.1× 159 0.9× 46 0.5× 22 958
Indira V. Kurup United States 10 84 0.3× 135 0.7× 95 0.5× 47 0.3× 108 1.1× 12 374
Michael Rosenbach United States 9 374 1.4× 159 0.9× 31 0.2× 132 0.8× 59 0.6× 9 671
M A Lafferty United States 10 439 1.6× 488 2.7× 114 0.6× 86 0.5× 849 8.5× 12 1.2k
Virginia Lezcano Argentina 10 444 1.7× 63 0.3× 189 1.0× 315 1.9× 34 0.3× 19 744
Yoshihiro Waki Japan 11 260 1.0× 43 0.2× 29 0.2× 200 1.2× 34 0.3× 23 560
Gaia Palmini Italy 11 328 1.2× 57 0.3× 54 0.3× 111 0.7× 33 0.3× 38 675
Mary-Beth McCarthy United States 13 324 1.2× 113 0.6× 12 0.1× 159 0.9× 65 0.7× 14 874

Countries citing papers authored by John D. Sallis

Since Specialization
Citations

This map shows the geographic impact of John D. Sallis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Sallis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Sallis more than expected).

Fields of papers citing papers by John D. Sallis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Sallis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Sallis. The network helps show where John D. Sallis may publish in the future.

Co-authorship network of co-authors of John D. Sallis

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Sallis. A scholar is included among the top collaborators of John D. Sallis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Sallis. John D. Sallis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheung, Herman S., John D. Sallis, Konstantinos D. Demadis, & Anthony S. Wierzbicki. (2006). Phosphocitrate blocks calcification‐induced articular joint degeneration in a guinea pig model. Arthritis & Rheumatism. 54(8). 2452–2461. 48 indexed citations
3.
Sallis, John D. & Herman S. Cheung. (2003). Inhibitors of articular calcium crystal formation. Current Opinion in Rheumatology. 15(3). 321–325. 8 indexed citations
5.
Nair, Deepu, Ravi Misra, John D. Sallis, & Herman S. Cheung. (1997). Phosphocitrate Inhibits a Basic Calcium Phosphate and Calcium Pyrophosphate Dihydrate Crystal-induced Mitogen-activated Protein Kinase Cascade Signal Transduction Pathway. Journal of Biological Chemistry. 272(30). 18920–18925. 71 indexed citations
6.
Cheung, Herman S., Indira V. Kurup, John D. Sallis, & Lawrence M. Ryan. (1996). Inhibition of Calcium Pyrophosphate Dihydrate Crystal Formation in Articular Cartilage Vesicles and Cartilage by Phosphocitrate. Journal of Biological Chemistry. 271(45). 28082–28085. 37 indexed citations
7.
Krug, Hollis E., Maren L. Mahowald, Paul B. Halverson, John D. Sallis, & Herman S. Cheung. (1993). Phosphocitrate prevents disease progression in murine progressive ankylosis. Arthritis & Rheumatism. 36(11). 1603–1611. 41 indexed citations
8.
Stagni, N., et al.. (1990). Evidence in vitro for an enzymatic synthesis of phosphocitrate. Biochemical and Biophysical Research Communications. 170(1). 251–258. 9 indexed citations
9.
Cheung, Herman S., John D. Sallis, Peter G. Mitchell, & Janine Struve. (1990). Inhibition of basic calcium phosphate crystal-induced mitogenesis by phosphocitrate. Biochemical and Biophysical Research Communications. 171(1). 20–25. 20 indexed citations
10.
Sallis, John D., et al.. (1989). Protection of crystal-induced polymorphonuclear leukocyte membranolysis by phosphocitrate. Biochemical Medicine and Metabolic Biology. 41(1). 56–63. 7 indexed citations
11.
Tsao, Jack W., Frederick J. Schoen, Ravi Shankar, John D. Sallis, & Robert J. Levy. (1988). Retardation of calcification of bovine pericardium used in bioprosthetic heart valves by phosphocitrate and a synthetic analogue. Biomaterials. 9(5). 393–397. 17 indexed citations
12.
Brown, Malcolm R., Ravi Shankar, & John D. Sallis. (1984). Synthesis of N‐[35S]‐sulpho‐2‐amino tricarballylate. Journal of Labelled Compounds and Radiopharmaceuticals. 21(10). 905–911. 2 indexed citations
13.
Williams, Gethin & John D. Sallis. (1982). Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation. Calcified Tissue International. 34(1). 169–177. 67 indexed citations
14.
Brown, Phyllis R., et al.. (1981). A comparative study of the whole blood nucleotide profiles of the tasmanian devil and other marsupials using high performance liquid chromatography. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 70(3). 541–547.
15.
Williams, Gethin & John D. Sallis. (1980). The synthesis of unlabeled and 32P-labeled phosphocitrate and analytical systems for its identification. Analytical Biochemistry. 102(2). 365–373. 27 indexed citations
16.
Sallis, John D., Hector F. DeLuca, & David L. Martin. (1965). Parathyroid Hormone-dependent Transport of Inorganic Phosphate by Rat Liver Mitochondria. Journal of Biological Chemistry. 240(5). 2229–2233. 12 indexed citations
17.
Rasmussen, Howard, John D. Sallis, Marie Fang, Hector F. DeLuca, & Richard Young. (1964). Parathyroid Hormone and Anion Uptake in Isolated Mitochondria. Endocrinology. 74(3). 388–394. 23 indexed citations
18.
Sallis, John D. & Hector F. DeLuca. (1964). Parathyroid Hormone Interaction with the Oxidative Phosphorylation Chain. Journal of Biological Chemistry. 239(12). 4303–4307. 16 indexed citations
19.
Sallis, John D., Hector F. DeLuca, & Howard Rasmussen. (1963). Parathyroid Hormone-dependent Uptake of Inorganic Phosphate by Mitochondria. Journal of Biological Chemistry. 238(12). 4098–4102. 52 indexed citations
20.
Sallis, John D., Hector F. DeLuca, & Howard Rasmussen. (1963). Parathyroid hormone stimulation of phosphate uptake by rat liver mitochondria. Biochemical and Biophysical Research Communications. 10(3). 266–270. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026